David Ralph

Company: Navidea Biopharmaceuticals

Job title: Senior Director, Drug Discovery

Seminars:

Mannosylated Amine Dextrans (MADs) as Small MW Drug Delivery Vehicles Targeting CD206 for Altering Macrophage Phenotypes 4:15 pm

MADs can deliver a wide variety of small molecule drug payloads specifically to CD206 (mannose receptor) expressing macrophages Understanding how MAD-drug constructs can induce durable changes in macrophage immune phenotypes that cannot be duplicated by the free drugs at any dose Revealing how MAD-drug constructs can increase the efficacy of anti-CTLA4 therapy in the CT26/Balb-c…Read more

day: Day Two